Traders should prepare for the April 29 earnings release, using the Aide Memoire as a reference for management's prior commentary and expectations. Monitor for updates on the Pivot to Growth strategy, generics performance, and debt levels during the call.
Price Chart
Executive Summary
Teva Pharmaceutical announced the date for its Q1 2026 earnings release on April 29, 2026, and published an Aide Memoire to assist investors in preparing for the results. The documents provide no actual financial data but confirm the timing of the upcoming earnings announcement and reiterate forward-looking statements about the company's strategic transformation.
Key Facts
- Teva will release Q1 2026 financial results on April 29, 2026, at 7:00 a.m. ET
- A conference call and webcast will follow at 8:00 a.m. ET on the same day
- An Aide Memoire has been posted to the investor relations website, based on previously disclosed information and external data
- No new financial results, guidance, or material updates were provided in either press release
Financial Impact
No immediate financial impact — no new data disclosed
Risk Factors
- Forward-looking statements are subject to risks including execution of the growth strategy, competitive pressures, and high indebtedness
- No assurance that actual results will align with prior management commentary or market expectations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 press releases from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259456 |
| PRESS-RELEASE Data (Synthetic) | press-3259458 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | Press Release | $36.35 $39.19 | ▲ +7.81% | ▲ +8.31% | $39.29 (+8.09%) |
Sep 8, 2026 24d ago | 424B5 | $36.76 $39.25 | ▲ +6.77% | ▲ +7.89% | $39.29 (+6.88%) |
Sep 2, 2026 4w ago | Court Ruling | $37.49 $36.35 | ▼ −3.04% | ▼ −2.08% | $39.29 (+4.80%) |
Aug 28, 2026 5w ago | Press Release | $36.44 $36.36 | ▼ −0.22% | ▼ −0.33% | $39.29 (+7.82%) |
Aug 25, 2026 5w ago | Court Ruling | $38.10 $36.20 | ▼ −4.99% | ▼ −4.46% | $39.29 (+3.12%) |
Aug 25, 2026 5w ago | Insider Cluster | $38.10 $36.20 | ▼ −4.99% | ▼ −4.46% | $39.29 (+3.12%) |
Aug 10, 2026 7w ago | Insider Cluster | $36.14 $36.46 | ▲ +0.89% | ▲ +0.93% | $39.29 (+8.72%) |
Aug 5, 2026 8w ago | Insider Cluster | $34.81 $36.45 | ▲ +4.70% | ▲ +3.49% | $39.29 (+12.87%) |
Jul 31, 2026 9w ago | Court Ruling | $35.01 $35.36 | ▲ +1.00% | ▼ −2.51% | $39.29 (+12.23%) |
Jul 29, 2026 9w ago | 8-K | $34.71 $34.72 | ▲ +0.03% | ▼ −5.50% | $39.29 (+13.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access